Insights On Facility Design

  1. Facilities And Capital Considerations For Continuous Manufacturing 5/16/2025

    We entertained several audience questions during our recent Bioprocess Online Live event Process Optimization or Full-Scale Automation. In this segment from the virtual event, David Bruehlmann addresses questions about facility considerations for continuous manufacturing, highlighting findings from Amgen and that indicate continuous enabled a considerably smaller facility footprint than batch. Considerations for new facility investment decisions.

  2. A Shift Towards Biofluorescent Particle Counters In Manufacturing 5/12/2025

    Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

  3. The Hidden Costs Of Equipment Storage: What You're Really Paying For 5/9/2025

    Don't let idle assets drain your resources. Uncover the often-overlooked expenses of equipment storage, from rental fees to lost opportunity costs, and learn how to reclaim value.

  4. Sourcing Pharmaceutical And Industrial Equipment In Auctions 5/9/2025

    More and more industrial gear is hitting the auction block. Unlock significant savings by understanding the nuances of pharmaceutical and industrial equipment auctions.

  5. New Vs. Used Processing Equipment: A Cost Comparison 5/9/2025

    For pharmaceutical and chemical manufacturers, balancing budgets with operational needs is crucial. Discover how sourcing used equipment offers significant cost advantages over new.

  6. PUPSIT Without The Pain: Practical Solutions For Implementation 5/6/2025

    Explore the critical role of pre-use post-sterilization integrity testing in quality risk management, as well as learn about integrity testing, wetting procedures, and innovative filtration systems for effective implementation.

  7. What Is The Position Of Regulatory Authorities On PUPSIT? 5/2/2025

    Implementing PUPSIT and other integrity testing methods is crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines for sterility.

  8. How Robotic Isolator Technology Aligns To Annex 1 Principles 4/28/2025

    Robotic gloveless isolators provide exceptional automation to eliminate human intervention and reduce contamination risk. Discover how they ensure compliance with the EU Annex 1 guideline to enhance sterility, precision, and monitoring.

  9. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

    Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

  10. CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics 4/28/2025

    CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.